Vision opens in NY, acquires Terphane

The London-based firm has opened a New York office and completed an investment in Brazilian manufacturer Terphane from Vision’s seventh fund.

ByGraham Winfrey

5 January 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals North America